Sort
261,768 grants matching “gene therapy”
Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies
$1,025,412Wenyi Wei · Beth Israel Deaconess Medical Center · R35 · FY2022 · CA
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,025,393Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2016 · CA
A Haplotype Map for Multiple Sclerosis
$1,025,276Stephen L Hauser · University Of California, San Francisco · R01 · FY2011 · NS
Molecular Analysis Of Retroviral Genes And Their Products
$1,025,169Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$1,025,166Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Biomarker and Phenotypic Risk Factors for Breast Cancer Lymphedema
$1,025,118Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2017 · CA
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
$1,025,117Adithya Cattamanchi · University Of California-Irvine · R01 · FY2024 · AI
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
$1,025,085Jonathan Michael Burg · Epicypher, Inc. · R44 · FY2022 · TR
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
$1,025,085Jonathan Michael Burg · Epicypher, Inc. · R44 · FY2023 · TR
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
$1,025,080Anthony Atala · Wake Forest University Health Sciences · R01 · FY2009 · EB
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy
$1,025,080Anthony Atala · Wake Forest University Health Sciences · R01 · FY2008 · EB
Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma
$1,025,001Margaret Kenny Offermann · Oncospherix, Inc. · R44 · FY2024 · CA
Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma
$1,024,999Margaret Kenny Offermann · Oncospherix, Inc. · R44 · FY2023 · CA
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$1,024,981Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
$1,024,973Yen Tun Wang · Curebiotech, Inc. · R44 · FY2019 · CA
IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection
$1,024,942Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2024 · AI
DNA Replication, Cancer and Chemotherapy
$1,024,926Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection
$1,024,879Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2025 · AI
Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands
$1,024,823Eric R Prossnitz · University Of New Mexico Health Scis Ctr · R01 · FY2025 · CA
Metrifonate local application for DFU treatment
$1,024,812Mark Allan Tepper · Epoulosis Therapeutics, Inc. · R44 · FY2025 · DK
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions
$1,024,766Cherie L Stabler · University Of Florida · UG3 · FY2020 · DK
Allogeneic Hematopoietic Transplantation for Primary Immunodeficiency Diseases
$1,024,731Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
$1,024,654Paul B Rosenberg · Johns Hopkins University · R01 · FY2016 · AG
Spatially-resolved protein and transcriptome mapping of senescent cells
$1,024,647Marissa Joy Schafer · Mayo Clinic Rochester · UH3 · FY2025 · CA
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,024,639Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2021 · HL